Delivering HOPE (Helping Women Optimize Prenatal Equity)
University of Arkansas · with Patient-Centered Outcomes Research Institute · NCT06814509
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 16–44 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1440
- US sites recruiting
- 7
- Study start
- June 24, 2025
- Record last updated
- June 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overarching research question is: "Does the provision of healthy food (Delivering HOPE) during pregnancy reduce the proportion of women who experience excessive gestational weight gain compared with enhanced standard of care (ESoC)?" To answer this question, the investigators will conduct a large multi-site randomized controlled trial with 1,440 women. Women will be randomized to either the Delivering HOPE arm or the ESoC arm, with approximately 720 participants per arm. Participants randomized to the ESoC arm will receive the standard clinical protocol for nutritional and gestational weight gain counseling recommended for all pregnant women, WIC and SNAP enrollment assistance, referrals to safety net food organizations.Those randomized to the Delivering HOPE arm will be provided the same nutritional and gestational weight gain counseling, WIC and SNAP assistance, and food referrals, as well as a total of $1000/$2000/$3000 (depending on household size) during pregnancy to be used specifically for the purchase of healthy foods recommended in the nutritional counseling. Data for the primary outcome (pre-pregnancy weight and weight at delivery) will be collected from birth records.
Being studied: Enhanced Standard of Care (ESoC); Delivering HOPE
Conditions: Gestational Weight Gain; Diet, Healthy; Gestational Hypertension; Gestational Diabetes; Pregnancy Complications
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aged 16-44 years
- ≤18 weeks pregnant
- Speak English, Spanish, or Marshallese
- Valid email address
Recruiting US locations
1st Choice Healthcare
Corning, AR 72422
Site contact: Sandra Green · deliveringhope@1stchoice-ar.org
River Valley Primary Care Services
Lavaca, AR 72941
Site contact: Laura Little · Womenshealth@rvpcs.org
Olly Neal Community Health Center
Marianna, AR 72360
Site contact: Karesha Freeman · deliveringhope@onchc.org
Boston Mountain Rural Health Center
Marshall, AR 72650
Site contact: Lisa Weaver · deliveringhope@bmrhc.net
Mainline Health Systems
Monticello, AR 71655
Site contact: Heath Reep · deliveringhope@mainlinehealth.net
Community Clinic
Springdale, AR 72764
Site contact: Lisa Stafford · deliveringhope@ccnwa.org
East Arkansas Family Health Center
West Memphis, AR 72301
Site contact: Barbara Daniels · DeliveringHope@eafhc.org
Study contacts (from the official record)
- Brett Rowland · 479-713-8000 · mbrowland@uams.edu
- Sarah Pollock · 479-713-8000 · SPollack@uams.edu
Similar studies in Arkansas
All diabetes studies in Arkansas →- RecruitingPhase 3
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Location
- Little Rock, AR + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
- Location
- Little Rock, AR + 55 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Little Rock, AR + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Little Rock, AR + 69 other US sites
- Eligibility basics
- Ages 18–80